Susana R. Louros

Susana R. Louros

Auto-generated profile, based on publicly available information

Susana R. Louros

Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK; Simons Initiative for the Developing Brain, Patrick Wild Centre, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CMCarlos A. Matos
Carlos A. Matos
CNClévio Nóbrega
Clévio Nóbrega
SLSusana R. Louros
Susana R. Louros
BABruno Almeida
Bruno Almeida
Elisabete FerreiroElisabete Ferreiro
Elisabete Ferreiro
ACAna Luísa Carvalho
Ana Luísa Carvalho
Different neurodegenerative diseases are caused by aberrant elongation of repeated glutamine sequences normally found in particular human proteins. Although the proteins involved are ubiquitously distributed in human tissues, toxicity targets only defined neuronal populations. Changes caused by an expanded polyglutamine protein are possibly influenced by endogenous cellular mechanisms, which may be harnessed to produce neuroprotection. Here, we show that ataxin-3, the protein involved in spinocerebellar ataxia type 3, also known as Machado-Joseph disease, causes dendritic and synapse loss in cultured neurons when expanded. We report that S12 of ataxin-3 is phosphorylated in neurons and that mutating this residue so as to mimic a constitutive phosphorylated state counters the neuromorphologic defects observed. In rats stereotaxically injected with expanded ataxin-3–encoding lentiviral vectors, mutation of serine 12 reduces aggregation, neuronal loss, and synapse loss. Our results suggest that S12 plays a role in the pathogenic pathways mediated by polyglutamine-expanded ataxin-3 and that phosphorylation of this residue protects against toxicity.

13 August 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HBHemant Bengani
Hemant Bengani
DGDetelina Grozeva
Detelina Grozeva
LMLambert Moyon
Lambert Moyon
SBShipra Bhatia
Shipra Bhatia
SLSusana R. Louros
Susana R. Louros
DFDavid R. FitzPatrick
David R. FitzPatrick
Identifying causative variants in cis-regulatory elements (CRE) in neurodevelopmental disorders has proven challenging. We have used in vivo functional analyses to categorize rigorously filtered CRE variants in a clinical cohort that is plausibly enriched for causative CRE mutations: 48 unrelated males with a family history consistent with X-linked intellectual disability (XLID) in whom no detectable cause could be identified in the coding regions of the X chromosome (chrX). Targeted sequencing of all chrX CRE identified six rare variants in five affected individuals that altered conserved bases in CRE targeting known XLID genes and segregated appropriately in families. Two of these variants, FMR1CRE and TENM1CRE, showed consistent site- and stage-specific differences of enhancer function in the developing zebrafish brain using dual-color fluorescent reporter assay. Mouse models were created for both variants. In male mice Fmr1CRE induced alterations in neurodevelopmental Fmr1 expression, olfactory behavior and neurophysiological indicators of FMRP function. The absence of another likely causative variant on whole genome sequencing further supported FMR1CRE as the likely basis of the XLID in this family. Tenm1CRE mice showed no phenotypic anomalies. Following the release of gnomAD 2.1, reanalysis showed that TENM1CRE exceeded the maximum plausible population frequency of a XLID causative allele. Assigning causative status to any ultra-rare CRE variant remains problematic and requires disease-relevant in vivo functional data from multiple sources. The sequential and bespoke nature of such analyses renders them time-consuming and challenging to scale for routine clinical use.

2 September 2024 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
NENagore Elu
Nagore Elu
SSSrividya Subash
Srividya Subash
SLSusana R. Louros
Susana R. Louros
\E\R\Nnagore Elu
\R\Nnagore Elu
Ubiquitination is one of the most conserved post-translational modifications and together with mRNA translation contributes to cellular protein homeostasis (proteostasis). Temporal and spatial regulation of proteostasis is particularly important during synaptic plasticity, when translation of specific mRNAs requires tight regulation. Mutations in genes encoding regulators of mRNA translation and in ubiquitin ligases have been associated with several neurodevelopmental disorders. RNA metabolism and translation are regulated by RNA-binding proteins, critical for the spatial and temporal control of translation in neurons. Several ubiquitin ligases also regulate RNA-dependent mechanisms in neurons, with numerous ubiquitination events described in splicing factors and ribosomal proteins. Here we will explore how ubiquitination regulates translation in neurons, from RNA biogenesis to alternative splicing and how dysregulation of ubiquitin signaling can be the underlying cause of pathology in neurodevelopmental disorders, such as Fragile X syndrome. Finally we propose that targeting ubiquitin signaling is an attractive novel therapeutic strategy for neurodevelopmental disorders where mRNA translation and ubiquitin signaling are disrupted.

11 December 2024 in STAR Protocols
Verified
Journal Article
Open access
BMBeatriz Maio
Beatriz Maio
NENagore Elu
Nagore Elu
CMCristina Martinez-Gonzalez
Cristina Martinez-Gonzalez
EOEmily K. Osterweil
Emily K. Osterweil
SLSusana R. Louros
Susana R. Louros
Cfos is an immediate early gene commonly used to identify neuronal activation. After loud sound stimulation, neurons in the inferior colliculus are activated and cFos is expressed in the nucleus. Here, we present a protocol for quantifying neuronal activity in response to auditory stimulation using cFos immunostaining in the mouse inferior colliculus. We then detail procedures for image acquisition and analysis. For complete details on the use and execution of this protocol, please refer to Louros et al.1.

8 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SSSang S. Seo
Sang S. Seo
SLSusana R. Louros
Susana R. Louros
NANatasha Anstey
Natasha Anstey
MGMiguel A. Gonzalez-Lozano
Miguel A. Gonzalez-Lozano
CHCallista B. Harper
Callista B. Harper
EOEmily K. Osterweil
Emily K. Osterweil
Dysregulated protein synthesis is a core pathogenic mechanism in Fragile X Syndrome (FX). The mGluR Theory of FX predicts that pathological synaptic changes arise from the excessive translation of mRNAs downstream of mGlu 1/5 activation. Here, we use a combination of CA1 pyramidal neuron-specific TRAP-seq and proteomics to identify the overtranslating mRNAs supporting exaggerated mGlu 1/5 -induced long-term synaptic depression (mGluR-LTD) in the FX mouse model ( Fmr1 -/y ). Surprisingly, our results identify a robust translation of ribosomal proteins (RPs) upon mGlu 1/5 stimulation that coincides with a reduced translation of long mRNAs encoding synaptic proteins. These changes are mimicked and occluded in Fmr1 -/y neurons. Inhibiting RP translation significantly impairs mGluR-LTD and prevents the length-dependent shift in the translating population. Together, these results suggest that pathological changes in FX result from a length-dependent alteration in the translating population that is supported by excessive RP translation.